CEO (Gene Therapy) XtRNA Location: Netherlands preferred, Europe-based with regular travel to Nijmegen Commitment: ~80% (approximately) Compensation: Primarily equity-based, modest base salary until fundraising Seniority: Founder/ leadership About the Venture (XtRNA Bio) XtRNA Bio is a
Bring lab-quality diagnostics into the operating theatre. At NBCL (Novel Biomarker Catalyst Lab), were developing Point-of-Care diagnostic solutions that deliver fast, simple, and accurate results exactly where clinicians need them — at the point of decision.
Bring lab-quality diagnostics into the operating theatre. At NBCL (Novel Biomarker Catalyst Lab), were developing Point-of-Care diagnostic solutions that deliver fast, simple, and accurate results exactly where clinicians need them — at the point of decision.